Skip to main content
Signal8

GC Corp.

SEC insider (Form 3/4/5 filer). CIK 0001931382. 10% Owner at Artiva Biotherapeutics, Inc. (ARTV). 2 reported Form 4/5 transactions since Sep 2024; latest on May 11, 2026. Located in YONGIN-SI.

Companies GC Corp. has filed insider reports for

  • Artiva Biotherapeutics, Inc. (ARTV): 10% Owner
GC Corp. profile photo

GC Corp.

CIK: 0001931382

Transaction Breakdown

Open Market Buys (P)2 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Artiva Biotherapeutics, Inc. logo
ARTV

Artiva Biotherapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    May 11, 2026
    Purchase
    Direct
    1.1M shares at avg. $11.52$12.5M
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    May 11, 2026
    Purchase
    Indirect
    347.2K shares at avg. $11.52$4.0M

1-2 of 2